Tweenvest Stocks

Elixiron Immunotherapeutics (Cayman) Limited (TPEX: 7871)

Health Care · Biotechnology · TW

NT$151.00

-1.95% today · +282.3% 1Y

Elixiron Immunotherapeutics (Cayman) Limited (TPEX: 7871) operates in the Biotechnology industry within the Health Care sector. The company is valued at $634.12M.

Over the last twelve months the share price has gained 282.3%, trading between 37.55 and 185.00.

Tweenvest scores Elixiron Immunotherapeutics (Cayman) Limited across four factors: quality 49/100, value 70/100. Its strongest factor is value.

7871 price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$634.12M
Revenue (TTM)
$3.56M
P/E
—
EPS
-1.17
Dividend yield
—
Beta (5Y)
—
52-week high
NT$185.00
52-week low
NT$37.55
Avg volume (3M)
—
Shares outstanding
134.28M
Employees
—
Next earnings
—
CompanyMarket capPriceDay
Beijing Bohui Innovation Biotechnology Group Co., Ltd.SZSE: 300318$646.39MCN¥5.30+1.34%
Crescent Biopharma, Inc.NasdaqCM: CBIO$638.16M$14.91+4.12%
Medigen Vaccine Biologics CorporationTPEX: 6547$637.45MNT$62.00+1.97%
CK Life Sciences Int'l., (Holdings) Inc.SEHK: 775$636.85MHK$0.52-1.89%
Sagimet Biosciences Inc.NasdaqGM: SGMT$633.21M$8.93-2.30%
Climb Bio, Inc.NasdaqGM: CLYM$631.80M$11.00+0.55%
Ironwood Pharmaceuticals, Inc.NasdaqGS: IRWD$631.22M$3.82-1.29%
Beijing Science Sun Pharmaceutical Co., Ltd.SZSE: 300485$616.28MCN¥8.57-0.92%

Browse every Biotechnology company →

Figures last refreshed Oct 11, 2026.